Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Cabotegravir
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Apretude 30mg tablets
0503010AWBCAAAA
|
Apretude | Cabotegravir | Infections | No data available |
|
Apretude 600mg/3ml prolonged-release inj vials
0503010AWBCABAB
|
Apretude | Cabotegravir | Infections | No data available |
|
Cabotegravir 30mg tablets
0503010AWAAAAAA
|
Cabotegravir | Cabotegravir | Infections | No data available |
|
Cabotegravir 600mg/3ml prolonged-release inj vials
0503010AWAAABAB
|
Cabotegravir | Cabotegravir | Infections | No data available |
|
Vocabria 30mg tablets
0503010AWBBAAAA
|
Vocabria | Cabotegravir | Infections | No data available |
|
Vocabria 600mg/3ml prolonged-release inj vials
0503010AWBBABAB
|
Vocabria | Cabotegravir | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.